Kiranmai Mandava

491 total citations
28 papers, 365 citations indexed

About

Kiranmai Mandava is a scholar working on Endocrinology, Diabetes and Metabolism, Plant Science and Molecular Biology. According to data from OpenAlex, Kiranmai Mandava has authored 28 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Plant Science and 4 papers in Molecular Biology. Recurrent topics in Kiranmai Mandava's work include Natural Antidiabetic Agents Studies (6 papers), Nanoparticles: synthesis and applications (4 papers) and Phytochemistry and biological activity of medicinal plants (3 papers). Kiranmai Mandava is often cited by papers focused on Natural Antidiabetic Agents Studies (6 papers), Nanoparticles: synthesis and applications (4 papers) and Phytochemistry and biological activity of medicinal plants (3 papers). Kiranmai Mandava collaborates with scholars based in India, Japan and United States. Kiranmai Mandava's co-authors include Mohammed Ibrahim, M. J. Nanjan, B. R. Prashantha Kumar, Saleemulla Khan, Rasheed A. Shaik, Mohammed Ibrahim, Mohammed Auwal Ibrahim, Sarangapani Manda, Marwa A. Ibrahim and Ayesha Sultana and has published in prestigious journals such as World Journal of Gastroenterology, BMC Complementary and Alternative Medicine and Heliyon.

In The Last Decade

Kiranmai Mandava

25 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiranmai Mandava India 10 93 65 63 60 57 28 365
Abayomi O. Adetuyi Nigeria 10 77 0.8× 66 1.0× 69 1.1× 60 1.0× 23 0.4× 16 393
Rahman Gul Pakistan 6 136 1.5× 32 0.5× 65 1.0× 106 1.8× 51 0.9× 24 401
Hussein Oyelola Bukoye Oloyede Nigeria 11 101 1.1× 50 0.8× 101 1.6× 72 1.2× 68 1.2× 27 422
Vadivel Arulmozhi India 7 101 1.1× 172 2.6× 91 1.4× 61 1.0× 77 1.4× 8 501
Hiva Alipanah Iran 12 95 1.0× 25 0.4× 119 1.9× 144 2.4× 44 0.8× 37 422
Fariba Najafi Iran 9 110 1.2× 79 1.2× 71 1.1× 90 1.5× 66 1.2× 20 372
Kamal Saroha India 9 85 0.9× 21 0.3× 52 0.8× 72 1.2× 32 0.6× 20 363
Binoy Varghese Cheriyan India 10 64 0.7× 41 0.6× 52 0.8× 28 0.5× 32 0.6× 51 296
B Dineshkumar India 8 99 1.1× 31 0.5× 51 0.8× 63 1.1× 53 0.9× 22 340
Musa Oyewole Salawu Nigeria 9 86 0.9× 38 0.6× 84 1.3× 55 0.9× 53 0.9× 31 336

Countries citing papers authored by Kiranmai Mandava

Since Specialization
Citations

This map shows the geographic impact of Kiranmai Mandava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiranmai Mandava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiranmai Mandava more than expected).

Fields of papers citing papers by Kiranmai Mandava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiranmai Mandava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiranmai Mandava. The network helps show where Kiranmai Mandava may publish in the future.

Co-authorship network of co-authors of Kiranmai Mandava

This figure shows the co-authorship network connecting the top 25 collaborators of Kiranmai Mandava. A scholar is included among the top collaborators of Kiranmai Mandava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiranmai Mandava. Kiranmai Mandava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mandava, Kiranmai, et al.. (2025). Comprehensive Review on How Repurposed Drugs Modulate Antitumor Immunity: Harnessing Damage-Associated Molecular Patterns. Cancer Biotherapy and Radiopharmaceuticals. 2076991403–2076991403.
4.
Mandava, Kiranmai, et al.. (2024). Formulation of Novel Boswellic Acid Loaded-PEGlyated Nanoparticles and Effect on SARS COVID 19 Virus: in silico Docking Analysis and ADMET Studies. Asian Journal of Chemistry. 36(6). 1409–1416. 1 indexed citations
5.
Mandava, Kiranmai, et al.. (2022). Dostarlimab, a boon or a healthcare burden- too early to acertain!. Annals of Medicine and Surgery. 79. 104050–104050. 1 indexed citations
6.
Sultana, Ayesha, et al.. (2022). Green Synthesis and Evaluation of Zinc Oxide Nanoparticles from Manilkara Zapota Leaf Extract. International Journal of Pharmaceutical Sciences and Nanotechnology. 15(1). 5822–5830. 2 indexed citations
7.
Mandava, Kiranmai, et al.. (2022). Monkeypox- a menacing challenge or an endemic?. Annals of Medicine and Surgery. 79. 103979–103979. 10 indexed citations
8.
Mandava, Kiranmai, et al.. (2022). CLInical Profile and Side Effects of chronic use of oral Amiodarone in cardiology outpatients department (CLIPSE-A Study)- A prospective observational study. Annals of Medicine and Surgery. 80. 104167–104167. 7 indexed citations
9.
Mandava, Kiranmai, et al.. (2021). Formulation and Evaluation of Ketoprofen Using β-Cyclodextrin Capped Silver Nanoparticles. International Journal of Pharmaceutical Sciences and Nanotechnology. 14(3). 5501–5507. 2 indexed citations
10.
Mandava, Kiranmai, et al.. (2019). Design and study of anticaries effect of different medicinal plants against S.mutans glucosyltransferase. BMC Complementary and Alternative Medicine. 19(1). 197–197. 17 indexed citations
11.
Mandava, Kiranmai, et al.. (2017). Formulation and evaluation of transdermal drug delivery of topiramate. International Journal of Pharmaceutical Investigation. 7(1). 10–10. 55 indexed citations
12.
Mandava, Kiranmai, et al.. (2013). PHARMACOGNOSTICAL, PHYTOCHEMICAL AND ANTICANCER STUDIES OF DENDROPHTHOE FALCATA (L.F.) ETTINGSH. (LORANTHACEAE) GROWING ON THE HOST PLANT AZADIRACHTA INDICA (MELIACEAE). International Journal of Pharma and Bio Sciences. 2 indexed citations
13.
Mandava, Kiranmai, et al.. (2012). Hepatoprotective Activity Of Phyllanthus Amarus Seeds Extracts In CCL4 Treated Rats: In Vitro and In Vivo. Journal of medical research/˜The œjournal of medical research. 12(6). 3 indexed citations
14.
Mandava, Kiranmai & Mohammed Ibrahim. (2012). ANTI BACTERIAL POTENTIAL OF DIFFERENT EXTRACTS OF TAGETES ERECTA LINN. International Journal of Pharmacy. 2(3). 90–96. 7 indexed citations
15.
Mandava, Kiranmai, et al.. (2012). Evaluation of total phenolic contents and antiulcerogenic activity of root bark of Azadirachta indica. Journal of medical research/˜The œjournal of medical research. 12(6). 3 indexed citations
16.
Ibrahim, Mohammed & Kiranmai Mandava. (2012). Successive solvent extraction and free radical scavenging activity of Azadirachta indica A. juss. International Journal of Green Pharmacy. 6(3). 237. 1 indexed citations
17.
Kumar, B. R. Prashantha, et al.. (2012). Discovery of novel glitazones incorporated with phenylalanine and tyrosine: Synthesis, antidiabetic activity and structure–activity relationships. Bioorganic Chemistry. 45. 12–28. 33 indexed citations
18.
Ibrahim, Mohammed Auwal & Kiranmai Mandava. (2012). Successive solvent extraction and free radical scavenging activity of Azadirachta indica A. juss. International Journal of Green Pharmacy. 6(3). 237–237. 5 indexed citations
19.
Mandava, Kiranmai, et al.. (2011). Comparison of total flavanoid content of Azadirachta indica root bark extracts prepared by different methods of extraction. Research Journal of Pharmaceutical Biological and Chemical Sciences. 2(3). 254–261. 75 indexed citations
20.
Khan, Saleemulla, et al.. (2009). Hepatoprotective evaluation of Anogeissus latifolia: In vitro and in vivo studies. World Journal of Gastroenterology. 15(38). 4816–4816. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026